Summit Therapeutics Inc. ( SMMT) - Stock Earnings
SMMT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
| Oct. 19, 2026 AfterMarket | — / — | — | — / — | — |
SMMT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -294.5 million USD | — USD |
| 2026Q1 | -250.1 million USD | — USD |
| 2026Q2 | -285.8 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
SMMT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -614.5 million USD | 704295 USD |
| 2024 | -221.9 million USD | — USD |
| 2025 | -1.5 billion USD | — USD |
| 2026 Est. | — | — |
SMMT
Price: $13.35
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 252593
Ebitda: -3.9 millionMarket Capitalization: 12.0 billion